Journal article covers

2023

Wang, R.; Kumar, P.; Reda, M.; Wallstrum, A. G.; Crumrine, N. A.; Ngamcherdtrakul, W.; Yantasee, W., Nanotechnology Applications in Breast Cancer Immunotherapy. Small, 2308639. | View Online

Reda, M.; Ngamcherdtrakul, W.; Wang, R.; Crumrine, N.; Baker, C.; Wallstrum, A.; Saito, J.; White, N.; Yantasee, W., Abstract 5119: Nano-immunotherapy targeting PD-L1, PLK1, and TLR9 for treatment of non-small cell lung cancer. Cancer Research (2023), 83 (7_Supplement), 5119-5119. | View Online

Ngamcherdtrakul, W.; Reda, M.; Baker, C.; Crumrine, N.; Wang, R.; Wallstrum, A.; White, N.; Saito, J.; Zaidan, H.; Rehwaldt, J.; Nelson, M.; Gray, J.; Yantasee, W., Abstract 3229: Triggering anti-tumor immune response with a nanotherapeutic that targets TLR9 and STAT3 pathways. Cancer Research (2023), 83 (7_Supplement), 3229-3229. | View Online

2022

Reda, M., Ngamcherdtrakul, W., Nelson, M.A., Siriwon, N., Wang, R., Zaidan, H.Y., Bejan, D.S., Reda, S., Hoang, N.H., Crumrine, N.A., Rehwaldt, J.C., Bindal, A., Mills, G.B., Gray, J.W., Yantasee, W. Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment. Nat Commun 13, 4261 (2022). View Online 

Ngamcherdtrakul, W., Bejan, D. S., Cruz-Muñoz, W., Reda, M., Zaidan, H.Y., Siriwon, N., Marshall, S., Wang, R., Nelson, M.A., Rehwaldt, J.P.C., Gray, J.W., Hynynen, K., Yantasee, W. Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis. Small, 2022. View Cover | View Online

2021

Yantasee, W., Amanda, L., Ngamcherdtrakul, W., Reda, M. Immunotherapeutic constructs and methods of their use, US Patent App. 2021, 16/999,948. | View Online

Yantasee, W., Reda, M., Ngamcherdtrakul, W. Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor,
US Patent App. 2021, 17/023,311. |View Online

Ngamcherdtrakul, W., Reda, M., Nelson, M.A., Wang, R., Zaidan, H.Y., Bejan, D.S., Hoang, N.H., Lane, R.S., Luoh, S., Leachman, S.A., Mills, G.B., Gray, J.W., Lund, A.W., Yantasee, W. In situ tumor vaccination with nanoparticle co-delivering CpG and STAT3 siRNA to effectively induce whole-body antitumor immune response. Advanced Materials, 2021, 33(31): 2100628.  View Cover | View Online

Nelson, M.A., Ngamcherdtrakul, W., Luoh, S., Yantasee, W. Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer. Cancer Metastasis and Reviews, 2021, 40: 519. | View Online

Salve, R., Kumar, P., Ngamcherdtrakul, W., Gajbhiye, V., Yantasee, W. Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery. Mater Sci Eng C Mater Biol Appl. 2021 May;124:112084. | View Online

2020

Reda, M., Bagley, A.F., Zaidan, H.Y., Yantasee, W. Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterials. Radiother Oncol. 2020 Sep;150:225-235.  | View Online

Schuemann, J., Bagley, A., Berbeco, R., et al. Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions, Phys Med Biol. 2020 Oct 22;65(21):21RM02. | View Online

2019

Ngamcherdtrakul, W., Yantasee, W. siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion. Translational Research. 2019 , 214: 105-120. | View Online

Reda, M., Ngamcherdtrakul, W., Gu, S., Bejan, D.S., Siriwon, N., Gray, J.W., Yantasee, W. PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer. Cancer Letters. 2019, 467:9-18. | View Online

Ngamcherdtrakul, W., Sangvanich, T., Goodyear, S., Reda, M., Gu, S., Castro, D.J., Punnakitikashem, P., and Yantasee, W. Lanthanide-Loaded Nanoparticles as Potential Fluorescent and Mass Probes for High-Content Protein Analysis, Bioengineering. 2019, 6(1), 23. | View online

Ngamcherdtrakul, W., Morry, J., Sangvanich, T., Reda, M., Bejan, D.S., Fryxell, G.E., Yantasee, W. Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model. Scientific Reports. 2019, 9:709, 1-9. | View online

Yantasee, W., Fryxell, G. E., Pattamakomsan, K., Sangvanich, T., Wiacek, R.J., Busche, B., Addleman, R.S., Timchalk, C., Ngamcherdtrakul, W., Siriwon, N. Selective capture of radionuclides (U, Pu, Th, Am and Co) using functional nanoporous sorbents. 2019, 366, 677–683. | View online 

2018

Gu, S., Ngamcherdtrakul, W., Reda, M., Hu, Z., Gray, J.W., Yantasee, W. Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment. PLoS One. 2018, 13(6):e0198141. | View PDF 

Ngamcherdtrakul, W., Sangvanich, T., Reda, M., Gu, S., Bejan, D., Yantasee, W. Lyophilization and Stability of Antibody Conjugated Mesoporous Silica Nanoparticle with Cationic Polymer and PEG for siRNA delivery. International Journal of Nanomedicine. 2018, 13, 4015–4027. | View Online

2017

Morry, J., Ngamcherdtrakul, W., Gu, S., Reda, M., Castro, D.J., Sangvanich, T., Gray, J.W., Yantasee, W. Targeted treatment of metastatic breast cancer by PLK1 siRNA delivered by an antioxidant nanoparticle platform. Molecular Cancer Therapeutics, 2017, 16(4):763-72. | View PDF

2016

Morry, J., Ngamcherdtrakul, W., Yantasee, W. Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles. Redox Biology, 2016, 11:240-253. | View PDF

Ngamcherdtrakul, W., Castro, D.J., Gu, S., Morry, J., Reda, M., Gray, J.W., Yantasee, W. Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment. Cancer Treatment Reviews, 2016, 45:19-29. | View Abstract

Gu, S., Hu, Z., Ngamcherdtrakul, W., Castro, D.J., Morry, J., Reda, M., Gray, J.W., Yantasee, W. Therapeutic siRNA for drug-resistant HER2-positive breast cancer. Oncotarget, 2016, 7(12): 14727-14741. | View PDF

2015

Morry, J., Ngamcherdtrakul, W., Gu, S., Goodyear. S., Castro, D., Reda, M., Sangvanich, T., Yantasee, W. Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis. Biomaterials, 2015, 66:41-52. | View PDF

Ngamcherdtrakul, W., Morry, J., Gu, S., Castro, D. J., Goodyear, S. M., Sangvanich, T., Reda, M. M., Lee, R., Mihelic, S. A., Beckman, B. L., Hu, Z., Gray, J. W., Yantasee, W. Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer. Advanced Functional Materials, 2015, 25(18), 2646-2659. View Cover | View PDF

2014

Sangvanich, T., Ngamcherdtrakul, W., Lee, R., Morry, J., Castro, D., Fryxell, G. E.,  Yantasee, W.  Nanoporous Sorbent Material as an Oral Phosphate Binder and for Aqueous Phosphate, Chromate, and Arsenate Removal. J Nanomed Nanotechnol, 2014, 5:4. View PDF

Sangvanich, T., Morry, J., Fox, C., Ngamcherdtrakul, W., Goodyear, S., Castro, D., Fryxell, G.E., Addleman, R.S., Summers, A.O., & Yantasee, W. Novel Oral Detoxification of Mercury, Cadmium, And Lead with Thiol-Modified Nanoporous Silica. ACS Applied Materials & Interfaces, 2014, 6 (8), 5483-5493. View PDF

2012

Yantasee, W, W. Chouyyok, RJ Wiacek, JA Creim, RS Addleman, GE Fryxell, CE Timchalk, Functionalized nanoporous silica for oral chelation therapy of a board range of radionuclides. Chapter 14 in Environmental Applications of Nanomaterials: Synthesis, Sorbents and Sensors, GE Fryxell and G Cao (eds), 2nd Edition, Imperial College Press, London, United Kingdom, 2012, pp. 369-379.

Davidson, J. D., Wiacek, R. J., Burton, S., Li, X. S., Fryxell, G. E., Addleman, R. S., Yantasee, W., Sangvanich, T. & Pattamakomsan, K. Improved deposition and deprotection of silane tethered 3,4 hydroxypyridinone (HOPO) ligands on functionalized nanoporous silica. Inorganic Chemistry Communications, 2012, 18(0), 92-96. View PDF

2010

Yantasee, W., Rutledge, R. D., Chouyyok, W., Sukwarotwat, V., Orr, G., Warner, C. L., Warner, M. G., Fryxell, G. E., Wiacek, R. J., Timchalk, C., & Addleman, R. S. Functionalized Nanoporous Silica for the Removal of Heavy Metals from Biological Systems: Adsorption and Application. ACS Applied Materials & Interfaces, 2010, 2 (10), 2749-2758. View Cover | View PDF

Yantasee, W., Fryxell, G.E., Porter, G.A., Pattamakomsan, K., Sukwarotwat, V., Chouyyok, W., Koonsiripaiboon, V., Xu, J., & Raymond, K.N. Novel Sorbents for Removal of Gadolinium-Based Contrast Agents in Sorbent Dialysis and Hemoperfusion: Preventive Approaches to Nephrogenic Systemic Fibrosis (NSF). (Feature article.) Nanomedicine: NBM, 2010, 6: 1-8. View Cover | View PDF

Chouyyok, W., Wiacek, R.J., Pattamakomsan, K., Sangvanich, T., Grudzien, R.M., Fryxell, G.E., & Yantasee, W. Phosphate removal by anion binding on functionalized nanoporous sorbents. Environ. Sci. Technol, 2010, 44(8):3073-3078. View PDF

Samuels, W., LaFemina, N., Sukwarotwat, V., Yantasee, W., & Fryxell, G.E. Chloromethylated activated carbon: A useful new synthon for making a novel class of sorbents for heavy metal separations, Sep. Sci. Technol, 2010, 45 (2): 288-235. View PDF

Warner, C. L., Addleman, R.S., Cinson, A. D., Droubay, T. C., Engelhard, M. H., Nash, M. A., Yantasee, W. & Warner, M. G. High-Performance, Superparamagnetic, Nanoparticle– Based Heavy Metal Sorbents for Removal of Contaminants from Natural Waters. ChemSusChem, 2010, 3 (6): 749–757. View Cover | View PDF

Sangvanich, T., Sukwarotwat, V., Wiacek, R.J., Grudzien, R.M., Fryxell, G.E., Addleman, R.S., Timchalk, C.& Yantasee, W. Selective Capture of Cesium and Thallium from Natural Waters and Simulated Wastes with Copper Ferrocyanide Functionalized Mesoporous Silica, Journal of Hazardous Materials, 2010, 182: 225-231. View PDF

Yantasee, W., Sangvanich, T., Creim, J.A., Pattamakomsan, K., Wiacek, R.J., Fryxell, G.E., Addleman, R.S., & Timchalk,C., Functional sorbents for selective capture of plutonium, americium, uranium, and thorium in blood, Health Physics J (special issue), 2010, 99 (3): 413-419. View PDF

Timchalk, C., Creim, J.A., Sukwarotwat, V., Wiacek, R., Addleman, S., Fryxell, G.E., & Yantasee, W. In Vitro and In Vivo Evaluation of a Novel Ferrocyanide Functionalized Nanopourous Silica Decorporation Agent for Cesium (Cs) in Rats, Health Physics J (special issue), 2010, 99 (3): 420-429. View PDF

Chouyyok, W., Shin, Y., Davidson, J., Samuels, W.D., LaFemina N.H., Rutledge, R.D., Fryxell, G.E., Sangvanich, T. & Yantasee, W. Selective removal of copper (II) from natural waters by nanoporous sorbents functionalized with chelating diamines. Environ. Sci. Technol., 2010, 44 (16): 6390-6395. View PDF

Warner, M.G., Warner, C.L., Addleman, R.S., & Yantasee, W. Magnetic Nanomaterials for Environmental Sensing. In Magnetic Nanomaterials: NmLS-Series, vol. 4, Wiley-VCH, 2010.

Addleman, R.S., Yantasee, W., Fryxell, G.E., Warner, M.G., Fontenot, S.A., Johnson, D.W., Bays, J.T., Warner, C.L. Nanostructured materials for selective collection of trace-level metals from aqueous systems. DT Pierce, JX Zhao (eds). In Trace Analysis with Nanomaterials, 2010.